Meet Our Experts

James Weisberger, MD
James Weisberger has been GenPath’s Chief Medical Officer since 2004. He is a recognized leader in hematopathology with more than 40 publications as abstracts or peer-reviewed journal articles. He has continued to teach, for more than 15 years, as a Clinical Associate Professor of Pathology and Medicine at the New York Medical College in Valhalla, New York. Dr. Weisberger was Chief Resident in Pathology at Westchester Medical Center and completed a fellowship in hematopathology at the New York-Cornell Medical Center under Dr. Daniel Knowles, an internationally recognized Hematopathologist. Dr. Weisberger earned both a BS and an MS from Stanford University and an MD from the University of Pennsylvania. Dr. Weisberger is board certified in internal medicine, hematopathology, and anatomic and clinical pathology.

Benjamin Solomon, MD
Ben Solomon is a board-certified pediatric geneticist who focuses on the use of genetics and genomics to identify, understand and care for patients with both rare and common genetic conditions as well as broad applications of genomic medicine.  In addition to his laboratory, clinical, and research leadership and advocacy, Dr. Solomon has authored over 100 peer-reviewed articles, book chapters, and textbooks, and is an active lecturer and educator.  Dr. Solomon attended medical school at the Geisel School of Medicine at Dartmouth, completed his residency and fellowship training in pediatrics and clinical genetics at the National Human Genome Research Institute at the National Institutes of Health and at Children’s National Medical Center, and served as Chief of the Division of Medical Genomics at the Inova Translational Medicine Institute.

Sherri Bale, PhD, FACMG
Sherri Bale is a Board-Certified Ph.D. Medical Geneticist, and a Founding Member of the American College of Medical Genetics. She has more than 35 years of experience in clinical, cytogenetic, and molecular genetics research and has authored over 140 papers, book chapters, and books in the field. Dr. Bale started GeneDx after 16 years at the National Institutes of Health, the last nine as head of the Genetic Studies Section in the Laboratory of Skin Biology at the NIAMS. She is known both nationally and internationally for her work in identifying the basis of hereditary diseases, especially those affecting the skin.

Guido D. Pollevick, PhD
Dr. Pollevick, GenPath’s Director of Molecular Genetics and Reproductive Genetics Departments, has more than 20 years of experience in the field of genetic testing. Formerly, he was the Director of Operations for Transgenomic Inc. and, prior to that, he held positions of Laboratory Director at several medical laboratories. Dr. Pollevick earned his Ph.D. from the University of Buenos Aires, Argentina, and is accredited in the United States by the International Education Research Foundation. He has held a certification of qualification as a laboratory director in genetic testing and oncology-molecular and cellular tumor markers from the New York State Department of Health since 2006. Dr. Pollevick has consistent success in biomedical scientific research, with more than 40 publications in the area of genetic conditions as peer-reviewed journal articles and has identified new genes associated with sudden cardiac death.